Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold.

Silica nanoparticles (SiO(2)) are widely used in biomedical applications such as drug delivery, cell tracking, and gene transfection. The capability to control the geometry, porosity, and surface characteristics of SiO(2) further provides new opportunities for their applications in nanomedicine. Concerns however remain about the potential toxic effects of SiO(2) upon exposure to biological systems. In the present study, the acute toxicity of SiO(2) of systematically varied geometry, porosity, and surface characteristics was evaluated in immune-competent mice when administered intravenously. Results suggest that in vivo toxicity of SiO(2) was mainly influenced by nanoparticle porosity and surface characteristics. The maximum tolerated dose (MTD) increased in the following order: mesoporous SiO(2) (aspect ratio 1, 2, 8) at 30-65 mg/kg < amine-modified mesoporous SiO(2) (aspect ratio 1, 2, 8) at 100-150 mg/kg < unmodified or amine-modified nonporous SiO(2) at 450 mg/kg. The adverse reactions above MTDs were primarily caused by the mechanical obstruction of SiO(2) in the vasculature that led to congestion in multiple vital organs and subsequent organ failure. It was revealed that hydrodynamic sizes of SiO(2) post-protein exposure had an important implication in relating SiO(2) physicochemical properties with their vasculature impact and resultant tolerance threshold, as the larger the hydrodynamic size in the presence of serum protein, the lower the MTD. This study sheds light on the rational design of SiO(2) to minimize in vivo toxicity and provides a critical guideline in selecting SiO(2) as the appropriate system for nanomedicine applications.

[1]  Zongxi Li,et al.  Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. , 2010, Small.

[2]  Yasuo Yoshioka,et al.  Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. , 2011, Nature nanotechnology.

[3]  Jiao Sun,et al.  Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways. , 2010, Biomaterials.

[4]  M Geso,et al.  Gold nanoparticles: a new X-ray contrast agent. , 2007, The British journal of radiology.

[5]  C. Haynes,et al.  Stability of small mesoporous silica nanoparticles in biological media. , 2011, Chemical communications.

[6]  Jianlin Shi,et al.  Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility , 2011 .

[7]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles for intracellular controlled drug delivery. , 2010, Small.

[8]  Linlin Li,et al.  Facile and Scalable Synthesis of Tailored Silica “Nanorattle” Structures , 2009 .

[9]  J. Pounds,et al.  Macrophage responses to silica nanoparticles are highly conserved across particle sizes. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[11]  Victor S-Y Lin,et al.  Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. , 2011, ACS nano.

[12]  Yaping Li,et al.  In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. , 2011, Small.

[13]  Victor S-Y Lin,et al.  Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. , 2006, Journal of the American Chemical Society.

[14]  Steven J. Shire,et al.  Viscosity Analysis of High Concentration Bovine Serum Albumin Aqueous Solutions , 2011, Pharmaceutical Research.

[15]  Dong Chen,et al.  In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. , 2010, ACS nano.

[16]  Ernesto L. Schiffrin,et al.  Endothelial dysfunction. , 2004, Journal of the American Society of Nephrology : JASN.

[17]  Jeffrey I. Zink,et al.  Dispersion and stability optimization of TiO2 nanoparticles in cell culture media. , 2010, Environmental science & technology.

[18]  Peter Wick,et al.  Nanotoxicology: an interdisciplinary challenge. , 2011, Angewandte Chemie.

[19]  Hamidreza Ghandehari,et al.  Cellular uptake and cytotoxicity of silica nanotubes. , 2008, Nano letters.

[20]  Feng Zhao,et al.  Acute toxicological effects of copper nanoparticles in vivo. , 2006, Toxicology letters.

[21]  V. Postnov,et al.  Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization, natural biodistribution, and acute toxicity , 2010, International journal of nanomedicine.

[22]  Yasuo Tsutsumi,et al.  Silica nanoparticles as hepatotoxicants. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  Parag Aggarwal,et al.  Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[24]  Hamidreza Ghandehari,et al.  Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. , 2011, ACS nano.

[25]  Xinglu Huang,et al.  Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. , 2011, Biomaterials.

[26]  Yu Tian,et al.  Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice , 2011, Nanotechnology.

[27]  E. Schiffrin,et al.  Endothelial dysfunction. , 2004, Journal of the American Society of Nephrology : JASN.

[28]  Robert Langer,et al.  The biocompatibility of mesoporous silicates. , 2008, Biomaterials.

[29]  Y. Tsutsumi,et al.  Effect of surface charge on nano-sized silica particles-induced liver injury. , 2011, Die Pharmazie.

[30]  Liyi Shi,et al.  Biodistribution and toxicity of intravenously administered silica nanoparticles in mice , 2010, Archives of Toxicology.

[31]  Guping Tang,et al.  In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection , 2009, Journal of applied toxicology : JAT.

[32]  V. Muzykantov Biomedical aspects of targeted delivery of drugs to pulmonary endothelium , 2005, Expert opinion on drug delivery.

[33]  Conrad Coester,et al.  Particle and Fibre Toxicology BioMed Central Methodology , 2008 .

[34]  Chen Chang,et al.  High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe. , 2008, Small.

[35]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.